deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT04614337

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) (OraGrowtH210)

A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)

Sponsor: Lumos Pharma

Conditions Growth Hormone Deficiency
Interventions LUM-201 rhGH Norditropin® pen (34 µg/kg)
Updated 28 times since 2020 Last updated: Oct 10, 2024 Started: Dec 31, 2020 Primary completion: Sep 4, 2024 Completion: Sep 4, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Growth Hormone Deficiency, this trial is completed. The trial is conducted by Lumos Pharma and has accumulated 28 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Feb 2023 · 3 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Oct 2023 · 4 months · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Mar 2024 · 3 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Sep 2025 · 10 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

28 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Nov 2024 — Sep 2025 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

▶ Show 23 earlier versions

  1. Dec 2023 — Mar 2024 [monthly]

    Active Not Recruiting PHASE2

  2. Nov 2023 — Dec 2023 [monthly]

    Active Not Recruiting PHASE2

  3. Oct 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE2

  4. Jun 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE2

  5. Apr 2023 — Jun 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

  7. Nov 2022 — Feb 2023 [monthly]

    Recruiting PHASE2

  8. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  9. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  10. May 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  11. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  12. Feb 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  13. Dec 2021 — Feb 2022 [monthly]

    Recruiting PHASE2

  14. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  15. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  16. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  17. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  18. May 2021 — Jun 2021 [monthly]

    Recruiting PHASE2

  19. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  20. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  21. Feb 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  22. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  23. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lumos Pharma
Data source: Lumos Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amarillo, United States , Atlanta, United States , Auckland, New Zealand , Bialystok, Poland , Buffalo, United States , Charleston, United States , Charlottesville, United States , Clayton, Australia , Columbus, United States , Fort Worth, United States and 32 more locations